Novartis reports new Phase III data showing secukinumab (AIN457) improved moderate-to-severe plaque psoriasis in patients
Source URL: https://qa1.novartis.us/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients-0
List of links present in page
- https://qa1.novartis.us/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients-0